Trials / Completed
CompletedNCT01395069
Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery
Randomized Clinical Trial Comparing Prophylactic Nepafenac 0.1% and Ketorolac 0.5% Versus Placebo in Preventing Postoperative Macular Edema After Uncomplicated Phacoemulsification Cataract Extraction (PNK)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 162 (actual)
- Sponsor
- Queen's University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Assess prophylactic efficacy of topical non-steroidal anti-inflammatory drops in preventing macular edema. Patient undergoing uncomplicated cataract surgery will be enrolled and randomized to nepafenac, ketorolac, or placebo. Follow-up will occur at 1 month with ocular coherence tomography (OCT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nepafenac 0.1% | 1 drop QID for 1 month |
| DRUG | Ketorolac 0.5% | 1 drop QID for 1 month |
| OTHER | Placebo (sterile saline drops) | 1 drop QID for 1 month |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2011-07-15
- Last updated
- 2016-01-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01395069. Inclusion in this directory is not an endorsement.